Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Population pharmacokinetics and personalized dosing of biapenem in infected inpatients at Nanjing Drum Tower Hospital
ChiCTR2300073976Phase 4Not yet recruiting
- Sponsor
- Nanjing Drum-Tower Hospital
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of biapenem in Infectious disease, sponsored by Nanjing Drum-Tower Hospital. Primary endpoint: Serum concentration of biapenem. Planned start Jul 2023; status: not yet recruiting.
02
Drugs
biapenem
03
Conditions
Infectious disease
Beyond the preview
Go deeper on ChiCTR2300073976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300073976.